Report Detail

Service & Software Global Drug Stability Testing Market Growth (Status and Outlook) 2022-2028

  • RnM4475784
  • |
  • 03 August, 2022
  • |
  • Global
  • |
  • 101 Pages
  • |
  • LPI(LP Information)
  • |
  • Service & Software

The global market for Drug Stability Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Drug Stability Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Drug Stability Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Drug Stability Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Drug Stability Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Drug Stability Testing players cover Q Laboratories, Consumer Product Testing℠ Company, Intertek Group, Auriga Research and Charles River Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Drug Stability Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Drug Stability Testing market, with both quantitative and qualitative data, to help readers understand how the Drug Stability Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Drug Stability Testing market and forecasts the market size by Type (Drug Substances and Finished Drug,), by Application (Pharmaceutical Factory, Laboratory and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Drug Substances
Finished Drug

Segmentation by application
Pharmaceutical Factory
Laboratory
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Q Laboratories
Consumer Product Testing℠ Company
Intertek Group
Auriga Research
Charles River Laboratories
SGS
Pacific BioLabs
Element Materials Technology
Catalent
Nelson Labs
PerkinElmer
BioProcess International
Ardena
Selvita

Chapter Introduction
Chapter 1: Scope of Drug Stability Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Drug Stability Testing market size and CAGR, Drug Stability Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Drug Stability Testing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Drug Stability Testing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Drug Stability Testing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Q Laboratories, Consumer Product Testing℠ Company, Intertek Group, Auriga Research, Charles River Laboratories, SGS, Pacific BioLabs, Element Materials Technology and Catalent, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Drug Stability Testing Market Size 2017-2028
    • 2.1.2 Drug Stability Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Drug Stability Testing Segment by Type
    • 2.2.1 Drug Substances
    • 2.2.2 Finished Drug
  • 2.3 Drug Stability Testing Market Size by Type
    • 2.3.1 Drug Stability Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Drug Stability Testing Market Size Market Share by Type (2017-2022)
  • 2.4 Drug Stability Testing Segment by Application
    • 2.4.1 Pharmaceutical Factory
    • 2.4.2 Laboratory
    • 2.4.3 Others
  • 2.5 Drug Stability Testing Market Size by Application
    • 2.5.1 Drug Stability Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Drug Stability Testing Market Size Market Share by Application (2017-2022)

3 Drug Stability Testing Market Size by Player

  • 3.1 Drug Stability Testing Market Size Market Share by Players
    • 3.1.1 Global Drug Stability Testing Revenue by Players (2020-2022)
    • 3.1.2 Global Drug Stability Testing Revenue Market Share by Players (2020-2022)
  • 3.2 Global Drug Stability Testing Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Drug Stability Testing by Regions

  • 4.1 Drug Stability Testing Market Size by Regions (2017-2022)
  • 4.2 Americas Drug Stability Testing Market Size Growth (2017-2022)
  • 4.3 APAC Drug Stability Testing Market Size Growth (2017-2022)
  • 4.4 Europe Drug Stability Testing Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Drug Stability Testing Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Drug Stability Testing Market Size by Country (2017-2022)
  • 5.2 Americas Drug Stability Testing Market Size by Type (2017-2022)
  • 5.3 Americas Drug Stability Testing Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Drug Stability Testing Market Size by Region (2017-2022)
  • 6.2 APAC Drug Stability Testing Market Size by Type (2017-2022)
  • 6.3 APAC Drug Stability Testing Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Drug Stability Testing by Country (2017-2022)
  • 7.2 Europe Drug Stability Testing Market Size by Type (2017-2022)
  • 7.3 Europe Drug Stability Testing Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Drug Stability Testing by Region (2017-2022)
  • 8.2 Middle East & Africa Drug Stability Testing Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Drug Stability Testing Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Drug Stability Testing Market Forecast

  • 10.1 Global Drug Stability Testing Forecast by Regions (2023-2028)
    • 10.1.1 Global Drug Stability Testing Forecast by Regions (2023-2028)
    • 10.1.2 Americas Drug Stability Testing Forecast
    • 10.1.3 APAC Drug Stability Testing Forecast
    • 10.1.4 Europe Drug Stability Testing Forecast
    • 10.1.5 Middle East & Africa Drug Stability Testing Forecast
  • 10.2 Americas Drug Stability Testing Forecast by Country (2023-2028)
    • 10.2.1 United States Drug Stability Testing Market Forecast
    • 10.2.2 Canada Drug Stability Testing Market Forecast
    • 10.2.3 Mexico Drug Stability Testing Market Forecast
    • 10.2.4 Brazil Drug Stability Testing Market Forecast
  • 10.3 APAC Drug Stability Testing Forecast by Region (2023-2028)
    • 10.3.1 China Drug Stability Testing Market Forecast
    • 10.3.2 Japan Drug Stability Testing Market Forecast
    • 10.3.3 Korea Drug Stability Testing Market Forecast
    • 10.3.4 Southeast Asia Drug Stability Testing Market Forecast
    • 10.3.5 India Drug Stability Testing Market Forecast
    • 10.3.6 Australia Drug Stability Testing Market Forecast
  • 10.4 Europe Drug Stability Testing Forecast by Country (2023-2028)
    • 10.4.1 Germany Drug Stability Testing Market Forecast
    • 10.4.2 France Drug Stability Testing Market Forecast
    • 10.4.3 UK Drug Stability Testing Market Forecast
    • 10.4.4 Italy Drug Stability Testing Market Forecast
    • 10.4.5 Russia Drug Stability Testing Market Forecast
  • 10.5 Middle East & Africa Drug Stability Testing Forecast by Region (2023-2028)
    • 10.5.1 Egypt Drug Stability Testing Market Forecast
    • 10.5.2 South Africa Drug Stability Testing Market Forecast
    • 10.5.3 Israel Drug Stability Testing Market Forecast
    • 10.5.4 Turkey Drug Stability Testing Market Forecast
    • 10.5.5 GCC Countries Drug Stability Testing Market Forecast
  • 10.6 Global Drug Stability Testing Forecast by Type (2023-2028)
  • 10.7 Global Drug Stability Testing Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Q Laboratories
    • 11.1.1 Q Laboratories Company Information
    • 11.1.2 Q Laboratories Drug Stability Testing Product Offered
    • 11.1.3 Q Laboratories Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Q Laboratories Main Business Overview
    • 11.1.5 Q Laboratories Latest Developments
  • 11.2 Consumer Product Testing℠ Company
    • 11.2.1 Consumer Product Testing℠ Company Company Information
    • 11.2.2 Consumer Product Testing℠ Company Drug Stability Testing Product Offered
    • 11.2.3 Consumer Product Testing℠ Company Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Consumer Product Testing℠ Company Main Business Overview
    • 11.2.5 Consumer Product Testing℠ Company Latest Developments
  • 11.3 Intertek Group
    • 11.3.1 Intertek Group Company Information
    • 11.3.2 Intertek Group Drug Stability Testing Product Offered
    • 11.3.3 Intertek Group Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Intertek Group Main Business Overview
    • 11.3.5 Intertek Group Latest Developments
  • 11.4 Auriga Research
    • 11.4.1 Auriga Research Company Information
    • 11.4.2 Auriga Research Drug Stability Testing Product Offered
    • 11.4.3 Auriga Research Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Auriga Research Main Business Overview
    • 11.4.5 Auriga Research Latest Developments
  • 11.5 Charles River Laboratories
    • 11.5.1 Charles River Laboratories Company Information
    • 11.5.2 Charles River Laboratories Drug Stability Testing Product Offered
    • 11.5.3 Charles River Laboratories Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Charles River Laboratories Main Business Overview
    • 11.5.5 Charles River Laboratories Latest Developments
  • 11.6 SGS
    • 11.6.1 SGS Company Information
    • 11.6.2 SGS Drug Stability Testing Product Offered
    • 11.6.3 SGS Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 SGS Main Business Overview
    • 11.6.5 SGS Latest Developments
  • 11.7 Pacific BioLabs
    • 11.7.1 Pacific BioLabs Company Information
    • 11.7.2 Pacific BioLabs Drug Stability Testing Product Offered
    • 11.7.3 Pacific BioLabs Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Pacific BioLabs Main Business Overview
    • 11.7.5 Pacific BioLabs Latest Developments
  • 11.8 Element Materials Technology
    • 11.8.1 Element Materials Technology Company Information
    • 11.8.2 Element Materials Technology Drug Stability Testing Product Offered
    • 11.8.3 Element Materials Technology Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Element Materials Technology Main Business Overview
    • 11.8.5 Element Materials Technology Latest Developments
  • 11.9 Catalent
    • 11.9.1 Catalent Company Information
    • 11.9.2 Catalent Drug Stability Testing Product Offered
    • 11.9.3 Catalent Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Catalent Main Business Overview
    • 11.9.5 Catalent Latest Developments
  • 11.10 Nelson Labs
    • 11.10.1 Nelson Labs Company Information
    • 11.10.2 Nelson Labs Drug Stability Testing Product Offered
    • 11.10.3 Nelson Labs Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Nelson Labs Main Business Overview
    • 11.10.5 Nelson Labs Latest Developments
  • 11.11 PerkinElmer
    • 11.11.1 PerkinElmer Company Information
    • 11.11.2 PerkinElmer Drug Stability Testing Product Offered
    • 11.11.3 PerkinElmer Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 PerkinElmer Main Business Overview
    • 11.11.5 PerkinElmer Latest Developments
  • 11.12 BioProcess International
    • 11.12.1 BioProcess International Company Information
    • 11.12.2 BioProcess International Drug Stability Testing Product Offered
    • 11.12.3 BioProcess International Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 BioProcess International Main Business Overview
    • 11.12.5 BioProcess International Latest Developments
  • 11.13 Ardena
    • 11.13.1 Ardena Company Information
    • 11.13.2 Ardena Drug Stability Testing Product Offered
    • 11.13.3 Ardena Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Ardena Main Business Overview
    • 11.13.5 Ardena Latest Developments
  • 11.14 Selvita
    • 11.14.1 Selvita Company Information
    • 11.14.2 Selvita Drug Stability Testing Product Offered
    • 11.14.3 Selvita Drug Stability Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Selvita Main Business Overview
    • 11.14.5 Selvita Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Drug Stability Testing. Industry analysis & Market Report on Drug Stability Testing is a syndicated market report, published as Global Drug Stability Testing Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Drug Stability Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,015.84
6,031.68
3,564.84
7,129.68
488,646.60
977,293.20
291,372.60
582,745.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report